|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| m-Xylene | CAS 108-38-3 | ||
| C6H4(CH3)2 | RTECS ZE2275000 | ||
|
Synonyms & Trade Names 1,3-Dimethylbenzene; meta-Xylene; m-Xylol |
DOT ID & Guide 1307 130 |
||
|
Exposure Limits |
NIOSH REL: TWA 100 ppm (435 mg/m3) ST 150 ppm (655 mg/m3) | ||
| OSHA PEL�: TWA 100 ppm (435 mg/m3) | |||
| IDLH 900 ppm | Conversion 1 ppm = 4.34 mg/m3 | ||
|
Physical Description Colorless liquid with an aromatic odor. |
|||
|
MW: 106.2 |
BP: 282°F |
FRZ: -54°F |
Sol: Slight |
|
VP: 9 mmHg |
IP: 8.56 eV |
|
Sp.Gr: 0.86 |
|
Fl.P: 82°F |
UEL: 7.0% |
LEL: 1.1% |
|
| Class IC Flammable Liquid: Fl.P. at or above 73�F and below 100�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, strong acids |
|||
|
Measurement Methods NIOSH 1501, 3800; OSHA 1002 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 900 ppm: (APF = 10) Any chemical cartridge respirator with organic vapor cartridge(s)*/(APF = 25) Any powered, air-purifying respirator with organic vapor cartridge(s)*/(APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, nose, throat; dizziness, excitement, drowsiness, incoordination, staggering gait; corneal vacuolization; anorexia, nausea, vomiting, abdominal pain; dermatitis | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, gastrointestinal tract, blood, liver, kidneys |
|
| See also: INTRODUCTION |